Morgan Stanley (NYSE:MS) Shares Sold by Marino Stram & Associates LLC

Marino Stram & Associates LLC decreased its holdings in Morgan Stanley (NYSE:MS) by 14.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 7,847 shares of the financial services provider’s stock after selling 1,333 shares during the quarter. Marino Stram & Associates LLC’s holdings in Morgan Stanley were worth $732,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new stake in shares of Morgan Stanley in the 4th quarter valued at $956,566,000. Moneta Group Investment Advisors LLC lifted its position in Morgan Stanley by 125,756.8% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 10,641,190 shares of the financial services provider’s stock worth $904,714,000 after acquiring an additional 10,632,735 shares during the last quarter. Boston Partners acquired a new position in Morgan Stanley during the 3rd quarter worth $477,765,000. Ontario Teachers Pension Plan Board acquired a new position in Morgan Stanley during the 1st quarter worth $451,711,000. Finally, FMR LLC lifted its position in Morgan Stanley by 21.2% during the 3rd quarter. FMR LLC now owns 23,474,452 shares of the financial services provider’s stock worth $1,917,159,000 after acquiring an additional 4,098,577 shares during the last quarter. Institutional investors and hedge funds own 84.19% of the company’s stock.

Morgan Stanley Trading Up 3.1 %

NYSE:MS traded up $2.70 during trading hours on Tuesday, hitting $89.69. The stock had a trading volume of 12,207,335 shares, compared to its average volume of 8,843,653. Morgan Stanley has a one year low of $69.42 and a one year high of $95.57. The company has a debt-to-equity ratio of 2.89, a quick ratio of 0.75 and a current ratio of 0.75. The company has a market cap of $145.89 billion, a price-to-earnings ratio of 17.35, a P/E/G ratio of 1.74 and a beta of 1.43. The business’s 50 day moving average is $88.59 and its 200-day moving average is $84.72.

Morgan Stanley (NYSE:MS) last issued its quarterly earnings data on Tuesday, April 16th. The financial services provider reported $2.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.30. The company had revenue of $15.14 billion during the quarter, compared to the consensus estimate of $14.42 billion. Morgan Stanley had a net margin of 9.49% and a return on equity of 10.36%. The firm’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.70 earnings per share. Sell-side analysts anticipate that Morgan Stanley will post 6.36 EPS for the current fiscal year.

Insider Transactions at Morgan Stanley

In other Morgan Stanley news, Chairman James P. Gorman sold 100,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $87.30, for a total value of $8,730,000.00. Following the transaction, the chairman now directly owns 350,000 shares of the company’s stock, valued at approximately $30,555,000. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, CFO Raja Akram sold 7,000 shares of the company’s stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $83.56, for a total value of $584,920.00. Following the completion of the sale, the chief financial officer now owns 97,634 shares in the company, valued at approximately $8,158,297.04. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Chairman James P. Gorman sold 100,000 shares of the stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $87.30, for a total transaction of $8,730,000.00. Following the transaction, the chairman now owns 350,000 shares of the company’s stock, valued at approximately $30,555,000. The disclosure for this sale can be found here. In the last 90 days, insiders sold 208,155 shares of company stock worth $18,149,314. 0.24% of the stock is owned by insiders.

Analyst Ratings Changes

MS has been the topic of several research reports. HSBC boosted their price objective on shares of Morgan Stanley from $96.00 to $100.00 and gave the stock a “hold” rating in a report on Thursday, March 28th. Oppenheimer lowered their target price on shares of Morgan Stanley from $109.00 to $97.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 19th. JMP Securities reissued a “market perform” rating on shares of Morgan Stanley in a research note on Tuesday, April 9th. Evercore ISI upped their target price on shares of Morgan Stanley from $97.00 to $102.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Finally, TheStreet raised shares of Morgan Stanley from a “c+” rating to a “b” rating in a research note on Wednesday, March 6th. Thirteen analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $95.48.

About Morgan Stanley

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.